Maxime Borgeaud

532 total citations · 1 hit paper
14 papers, 285 citations indexed

About

Maxime Borgeaud is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Maxime Borgeaud has authored 14 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Maxime Borgeaud's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (3 papers). Maxime Borgeaud is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (3 papers). Maxime Borgeaud collaborates with scholars based in Switzerland, United States and United Kingdom. Maxime Borgeaud's co-authors include Alfredo Addeo, Alex Friedlaender, Giuseppe Luigi Banna, Olivier Michielin, José Luís Sandoval, Michel Obéid, Timothée Olivier, Xiuning Le, Kaushal Parikh and Petros Tsantoulis and has published in prestigious journals such as SHILAP Revista de lepidopterología, CA A Cancer Journal for Clinicians and Cancer Treatment Reviews.

In The Last Decade

Maxime Borgeaud

12 papers receiving 281 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

2021 157 citations Maxime Borgeaud, Alfredo Addeo et al. World Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxime Borgeaud Switzerland	5	171	150	88	52	45	14	285
Nicolas Brandone France	5	177 1.0×	155 1.0×	59 0.7×	43 0.8×	35 0.8×	8	249
Jingying Nong China	9	184 1.1×	210 1.4×	67 0.8×	89 1.7×	24 0.5×	32	293
Amy Hankin United States	7	161 0.9×	78 0.5×	77 0.9×	41 0.8×	58 1.3×	28	210
Linpeng Zheng China	10	207 1.2×	150 1.0×	77 0.9×	71 1.4×	37 0.8×	17	304
Minae An South Korea	6	189 1.1×	95 0.6×	110 1.3×	49 0.9×	79 1.8×	10	309
Marta Román Spain	5	116 0.7×	126 0.8×	168 1.9×	68 1.3×	23 0.5×	7	306
Fenghuan Sun China	4	211 1.2×	135 0.9×	104 1.2×	57 1.1×	151 3.4×	8	355
James J. Saller United States	8	142 0.8×	75 0.5×	119 1.4×	46 0.9×	47 1.0×	25	275
Santiago Ponce-Aix Spain	11	199 1.2×	233 1.6×	159 1.8×	59 1.1×	34 0.8×	17	425

Countries citing papers authored by Maxime Borgeaud

Since Specialization

Citations

This map shows the geographic impact of Maxime Borgeaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Borgeaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Borgeaud more than expected).

Fields of papers citing papers by Maxime Borgeaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Borgeaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Borgeaud. The network helps show where Maxime Borgeaud may publish in the future.

Co-authorship network of co-authors of Maxime Borgeaud

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Borgeaud. A scholar is included among the top collaborators of Maxime Borgeaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Borgeaud. Maxime Borgeaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Borgeaud, Maxime, et al.. (2025). Dormant Tumor Cells: Current Opportunities and Challenges in Clinical Practice. SHILAP Revista de lepidopterología. 5(1). 3–3. 2 indexed citations

2.

Borgeaud, Maxime, Montserrat Alvarez, Olivier Preynat‐Seauve, et al.. (2025). Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma. JCI Insight. 10(14). 1 indexed citations

3.

Imbimbo, Martina, Maxime Borgeaud, Margaret Ottaviano, et al.. (2025). Thymic epithelial tumors: what’s new and what’s next?. 4. 100024–100024. 1 indexed citations

4.

Borgeaud, Maxime, Timothée Olivier, Jair Bar, et al.. (2025). Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management. CA A Cancer Journal for Clinicians. 75(5). 387–409. 3 indexed citations

5.

Mariniello, Annapaola, et al.. (2025). Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back. BioDrugs. 39(2). 215–235. 4 indexed citations

6.

Borgeaud, Maxime, et al.. (2024). Management of stage III non-small-cell lung cancer: rays of hope. SHILAP Revista de lepidopterología. 5(1). 85–95. 3 indexed citations

7.

Borgeaud, Maxime, Kaushal Parikh, Giuseppe Luigi Banna, et al.. (2024). Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review. Journal of Thoracic Oncology. 19(7). 973–983. 27 indexed citations

8.

Tavernari, Daniele, Maxime Borgeaud, Ximeng Liu, et al.. (2024). Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief Report. Journal of Thoracic Oncology. 20(4). 500–506. 4 indexed citations

9.

Borgeaud, Maxime, et al.. (2024). Rates of febrile neutropenia and its causes in the real world. Future Oncology. 20(29). 2203–2212.

10.

Borgeaud, Maxime, et al.. (2023). Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers – Current Landscape. Praxis. 112(3). 149–155. 1 indexed citations

11.

Borgeaud, Maxime, José Luís Sandoval, Michel Obéid, et al.. (2023). Novel targets for immune-checkpoint inhibition in cancer. Cancer Treatment Reviews. 120. 102614–102614. 76 indexed citations

12.

Borgeaud, Maxime, et al.. (2023). The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma. Journal of Clinical Medicine. 12(5). 1757–1757. 6 indexed citations

13.

Borgeaud, Maxime, et al.. (2021). Oncogenic driver mutations in non-small cell lung cancer: Past, present and future. World Journal of Clinical Oncology. 12(4). 217–237. 157 indexed citations breakdown →

14.

Astaras, Christoforos, et al.. (2021). The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer. SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact